• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响早期乳腺癌患者乳腺癌根治术后局部区域复发的预后因素:内在亚型是否有效?

Prognostic factors affecting postmastectomy locoregional recurrence in patients with early breast cancer: are intrinsic subtypes effective?

机构信息

Department of Surgery, Ankara Oncology Training and Research Hospital, Ankara, Turkey.

出版信息

World J Surg. 2011 Oct;35(10):2196-202. doi: 10.1007/s00268-011-1240-2.

DOI:10.1007/s00268-011-1240-2
PMID:21853356
Abstract

BACKGROUND

Many studies have investigated the association between the molecular subtypes of breast cancer and survival. The aim of this study was to identify the effects of intrinsic subtypes of breast cancer and the other clinicopathological factors on postmastectomy locoregional recurrence (LRR) in patients with early breast cancer.

METHODS

The records of 1,195 consecutive early breast cancer patients treated with modified radical mastectomy between 2004 and 2008 were retrospectively evaluated. The effects of intrinsic subtypes of the tumor (luminal A, luminal B, HER2-overexpressing, and triple-negative) and classical clinicopathological factors on LRR were identified by univariate and multivariate statistical analyses.

RESULTS

The median follow-up time was 44 months, and 16 (1.3%) patients experienced a LRR during this period. In univariate analysis, the intrinsic subtypes of breast cancer had a significant effect on LRR (p = 0.002). In multivariate analysis, only extranodal invasion and estrogen receptor (ER) status were significant predictors of LRR (p = 0.003 and 0.0001, respectively), whereas intrinsic subtypes did not reveal a significant relationship with LRR (p = 0.57; hazard ratio, 2.9; 95% confidence interval, 0.2-4.7).

CONCLUSIONS

The results of this study suggest that the extranodal invasion and negative ER status should potentially be considered when evaluating the risk of LRR. The predictive power of intrinsic subtypes for LRR is less than that of classical pathological indicators. This information may be useful in planning management of LRR in early breast cancer patients treated with mastectomy.

摘要

背景

许多研究已经探讨了乳腺癌分子亚型与生存之间的关系。本研究的目的是确定乳腺癌内在亚型和其他临床病理因素对早期乳腺癌患者乳腺癌根治术后局部区域复发(LRR)的影响。

方法

回顾性评估了 2004 年至 2008 年间接受改良根治性乳房切除术的 1195 例连续早期乳腺癌患者的记录。通过单因素和多因素统计分析,确定肿瘤内在亚型(管腔 A、管腔 B、HER2 过表达和三阴性)和经典临床病理因素对 LRR 的影响。

结果

中位随访时间为 44 个月,在此期间 16 例(1.3%)患者发生 LRR。在单因素分析中,乳腺癌内在亚型对 LRR 有显著影响(p = 0.002)。在多因素分析中,仅淋巴结外侵犯和雌激素受体(ER)状态是 LRR 的显著预测因素(p = 0.003 和 0.0001),而内在亚型与 LRR 无显著关系(p = 0.57;危险比,2.9;95%置信区间,0.2-4.7)。

结论

本研究结果表明,在评估 LRR 风险时,应考虑淋巴结外侵犯和 ER 状态阴性。内在亚型对 LRR 的预测能力小于经典病理指标。这些信息可能有助于计划接受乳房切除术的早期乳腺癌患者的 LRR 管理。

相似文献

1
Prognostic factors affecting postmastectomy locoregional recurrence in patients with early breast cancer: are intrinsic subtypes effective?影响早期乳腺癌患者乳腺癌根治术后局部区域复发的预后因素:内在亚型是否有效?
World J Surg. 2011 Oct;35(10):2196-202. doi: 10.1007/s00268-011-1240-2.
2
Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients.生物学亚型可预测中国乳腺癌患者乳房切除术后放疗后的局部区域复发。
Cancer Med. 2020 Apr;9(7):2427-2434. doi: 10.1002/cam4.2904. Epub 2020 Feb 12.
3
Effect of postmastectomy radiotherapy on pTN breast cancer patients with different molecular subtypes.保乳术后放疗对不同分子亚型 pTN 乳腺癌患者的影响。
Breast. 2022 Feb;61:108-117. doi: 10.1016/j.breast.2021.12.013. Epub 2021 Dec 17.
4
Prognostic value of molecular subtypes, ki67 expression and impact of postmastectomy radiation therapy in breast cancer patients with negative lymph nodes after mastectomy.乳腺癌患者术后淋巴结阴性患者中分子亚型、Ki67 表达的预后价值及术后放疗的影响。
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1123-32. doi: 10.1016/j.ijrobp.2012.02.047. Epub 2012 May 8.
5
Is biological subtype prognostic of locoregional recurrence risk in women with pT1-2N0 breast cancer treated with mastectomy?行保乳术治疗的 pT1-2N0 乳腺癌女性,生物学亚型是否与局部区域复发风险相关?
Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):57-64. doi: 10.1016/j.ijrobp.2013.09.024. Epub 2013 Oct 22.
6
Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.早期三阴性乳腺癌行乳房切除术而未行辅助放疗的分析:失败模式和预后因素。
Cancer. 2013 Jul 1;119(13):2366-74. doi: 10.1002/cncr.28085. Epub 2013 Apr 10.
7
Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.选择具有T1-T2肿瘤且腋窝淋巴结有1至3个阳性、保乳术后局部区域复发风险高的乳腺癌患者进行辅助放疗。
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47. doi: 10.1016/j.ijrobp.2004.08.009.
8
Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.腋窝淋巴结1 - 3个阳性且未接受辅助放疗的乳房切除术后患者的局部区域复发
Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):980-8. doi: 10.1016/s0360-3016(01)02724-9.
9
Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.基于阿霉素的化疗及乳房切除术后的局部区域复发:对早期乳腺癌患者的影响及乳房切除术后放疗后复发的预测因素
Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):336-44. doi: 10.1016/s0360-3016(03)00593-5.
10
Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status.放疗可降低 T1 至 T2 乳腺癌且腋窝淋巴结 1 至 3 个转移、雌激素受体阴性和脉管侵犯阳性的乳腺癌改良根治术后患者的局部区域复发率并提高生存率。
Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):516-22. doi: 10.1016/j.ijrobp.2009.05.016. Epub 2009 Jul 4.

引用本文的文献

1
Prognostic Value of Salivary Biochemical Indicators in Primary Resectable Breast Cancer.唾液生化指标在原发性可切除乳腺癌中的预后价值
Metabolites. 2022 Jun 16;12(6):552. doi: 10.3390/metabo12060552.
2
Location and Frequency of Residual Breast Tissue after Mastectomy.乳房切除术后残余乳腺组织的位置及发生率
Breast Care (Basel). 2019 Aug;14(4):212-215. doi: 10.1159/000494765. Epub 2019 Mar 14.
3
The reciprocal influences of prognosis between two types of surgical interventions and early breast cancer patients with diverse luminal subtypes: A meta-analysis.

本文引用的文献

1
Breast cancer subtypes and the risk of local and regional relapse.乳腺癌亚型与局部和区域复发的风险。
J Clin Oncol. 2010 Apr 1;28(10):1684-91. doi: 10.1200/JCO.2009.24.9284. Epub 2010 Mar 1.
2
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.使用五生物标志物组合预测早期浸润性乳腺癌保乳治疗后的局部复发、远处转移和死亡情况。
J Clin Oncol. 2009 Oct 1;27(28):4701-8. doi: 10.1200/JCO.2008.21.7075. Epub 2009 Aug 31.
3
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors.
两种手术干预措施与不同腔面亚型早期乳腺癌患者预后的相互影响:一项荟萃分析。
Medicine (Baltimore). 2019 Mar;98(11):e14912. doi: 10.1097/MD.0000000000014912.
4
Survival Analysis Based on Clinicopathological Data from a Single Institution: Chemotherapy Intensity Would Be Enhanced in Patients with Positive Hormone Receptors and Positive HER2 in China Who Cannot Afford the Target Therapy.基于单机构临床病理数据的生存分析:在中国,对于无法负担靶向治疗的激素受体阳性且HER2阳性患者,化疗强度应增加。
ISRN Oncol. 2013 Jul 30;2013:606398. doi: 10.1155/2013/606398. eCollection 2013.
两种前瞻性乳腺癌幸存者队列研究中乳腺癌亚型的流行病学。
Breast Cancer Res. 2009;11(3):R31. doi: 10.1186/bcr2261. Epub 2009 May 22.
4
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.通过雌激素受体、孕激素受体和人表皮生长因子受体2来近似划分的乳腺癌亚型与保乳治疗后的局部和远处复发相关。
J Clin Oncol. 2008 May 10;26(14):2373-8. doi: 10.1200/JCO.2007.14.4287. Epub 2008 Apr 14.
5
How basal are triple-negative breast cancers?三阴性乳腺癌的基础情况如何?
Int J Cancer. 2008 Jul 1;123(1):236-40. doi: 10.1002/ijc.23518.
6
The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.人表皮生长因子受体2在雌激素和孕激素受体阴性浸润性乳腺癌女性患者生存中的作用:加利福尼亚癌症登记处,1999 - 2004年
Cancer. 2008 Feb 15;112(4):737-47. doi: 10.1002/cncr.23243.
7
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.三阴性乳腺癌:在接受蒽环类辅助治疗的患者中的分子特征及预后影响
Breast Cancer Res Treat. 2008 Sep;111(1):27-44. doi: 10.1007/s10549-007-9756-8. Epub 2007 Oct 6.
8
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races.不同种族乳腺癌患者内在亚型的患病率及预后
Breast. 2007 Dec;16 Suppl 2:S72-7. doi: 10.1016/j.breast.2007.07.017. Epub 2007 Aug 21.
9
Post-mastectomy radiation therapy: translating local benefits into improved survival.乳房切除术后放射治疗:将局部获益转化为生存改善
Breast. 2007 Dec;16 Suppl 2:S78-83. doi: 10.1016/j.breast.2007.07.018. Epub 2007 Aug 21.
10
Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers.三阴性表型能否准确识别基底样肿瘤?基于143例“三阴性”乳腺癌的免疫组织化学分析。
Ann Oncol. 2007 Jul;18(7):1285-6. doi: 10.1093/annonc/mdm360.